Journal of Translational Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +44-1625-708989

Mini Review - Journal of Translational Research (2018) Volume 2, Issue 1

VXc-486 potent drug: A new drug approach in tuberculosis treatment.

Tuberculosis (TB) is a communicable disease sometimes caused by the microorganism mycobacterium tuberculosis (MTB). Anti-tubercular agents inhibit the growth of Mycobacterium tuberculosis. Anti-tubercular agents mainly act by inhibit the growth of bacteria by cell wall synthesis inhibition. VXc-486 is a potent anti-tubercular drug belonging with aminobenzimidazole category. The novel amino-benzimidazole, VXc-486, which targets gyrase B, potently inhibits multiple drug-sensitive isolates and drug-resistant isolates of Mycobacterium tuberculosis. VXc-486 is crystalline and flakes in yellow color having solid state. It is crystalline solid at room temperature that show physical characteristic of the drug. VXc-486 is water insoluble potent anti-tubercular drug which is the Amino-benzimidazole family drug

Author(s): Sharma AK, Sharma V, Rathor R, Khandelwal M, Sharma M

Abstract Full Text PDF